Abstract:Use of probiotic biofilms can be an alternative approach for reducing the formation of pathogenic biofilms in food industries. The aims of this study were (i) to evaluate the probiotic properties of bacteriocinogenic (Lactococcus lactis VB69, L. lactis VB94, Lactobacillus sakei MBSa1, and Lactobacillus curvatus MBSa3) and non-bacteriocinogenic (L. lactis 368, Lactobacillus helveticus 354, Lactobacillus casei 40, and Weissela viridescens 113) lactic acid bacteria (LAB) isolated from Brazilian's foods and (ii) to develop protective biofilms with these strains and test them for exclusion of Listeria monocytogenes, Escherichia coli O157:H7, and Salmonella Typhimurium. LAB were tested for survival in acid and bile salt conditions, surface properties, biosurfactant production, β-galactosidase and gelatinase activity, antibiotic resistance and presence of virulence genes. Most strains survived exposure to pH 2 and 4% bile salts. The highest percentages of auto-aggregation were obtained after 24 h of incubation. Sixty-seven percentage auto-aggregation value was observed in W. viridescens 113 and Lactobacillus curvatus MBSa3 exhibited the highest co-aggregation (69% with Listeria monocytogenes and 74.6% with E. coli O157:H7), while the lowest co-aggregation was exhibited by W. viridescens 113 (53.4% with Listeria monocytogenes and 38% with E. coli O157:H7). Tests for hemolytic activity, bacterial cell adherence with xylene, and drop collapse confirmed the biosurfactant-producing ability of most strains. Only one strain (L. lactis 368) produced β-galactosidase. All strains were negative for virulence genes cob, ccf, cylLL, cylLs, cyllM, cylB, cylA and efaAfs and gelatinase production. The antibiotic susceptibility tests indicated that the MIC for ciprofloxacin, clindamycin, gentamicin, kanamycin, and streptomycin did not exceed the epidemiological cut-off suggested by the European Food Safety Authority. Some strains were resistant to one or more antibiotics and resistance to antibiotics was species and strain dependent. In the protective biofilm assays, strains L. lactis 368 (bac-), Lactobacillus curvatus MBSa3 (bac+), and Lactobacillus sakei MBSa1 (bac+) resulted in more than six log reductions in the pathogens counts when compared to the controls. This effect could not be attributed to bacteriocin production. These results suggest that these potential probiotic strains can be used as alternatives for control of biofilm formation by pathogenic bacteria in the food industry, without conferring a risk to the consumers.

Research progress on the regulatory mechanism of biofilm formation in probiotic lactic acid bacteria

Biofilms in Plant-Based Fermented Foods: Formation Mechanisms, Benefits and Drawbacks on Quality and Safety, and Functionalization Strategies

Microbial Biofilms: a Comprehensive Review of Their Properties, Beneficial Roles and Applications

Quorum Sensing of Lactic Acid Bacteria: Progress and Insights

Lactic acid bacteria biofilms and their antimicrobial potential against pathogenic microorganisms

Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut

Lactobacillus-derived components for inhibiting biofilm formation in the food industry

Elimination of Pathogen Biofilms via Postbiotics from Lactic Acid Bacteria: A Promising Method in Food and Biomedicine

The Association of Biofilm Formation with Antibiotic Resistance in Lactic Acid Bacteria from Fermented Foods

Comparative analysis of biofilm characterization of probiotic Escherichia coli

Stress tolerance and characterization of biofilm-like probiotic bacteria encapsulated in calcium pectin beads

The inhibition mechanism of co-cultured probiotics on biofilm formation of Klebsiella pneumoniae

Lactobacillus reuteri biofilms formed on porous zein/cellulose scaffolds: Synbiotics to regulate intestinal microbiota

Integration of Transcriptome and Metabolome Reveals the Genes and Metabolites Involved in Bifidobacterium bifidum Biofilm Formation

Multiomics Reveals the Mechanism of B. Longum in Promoting the Formation of Mixed-Species Biofilms.

Improving the Viability of Probiotics under Harsh Conditions by the Formation of Biofilm on Electrospun Nanofiber Mat

Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic

Regulating bacterial biofilms in food and biomedicine: unraveling mechanisms and Innovating strategies

Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier

Mechanisms and Improvement of Acid Resistance in Lactic Acid Bacteria

Use of Potential Probiotic Lactic Acid Bacteria (LAB) Biofilms for the Control of Listeria monocytogenes, Salmonella Typhimurium, and Escherichia coli O157:H7 Biofilms Formation